|
GNG12 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.010100E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.023700E-03 |
| Normal-vs-Stage2 |
3.257700E-03 |
| Normal-vs-Stage3 |
2.199100E-03 |
| Normal-vs-Stage4 |
6.788800E-04 |
| Stage1-vs-Stage2 |
3.440800E-01 |
| Stage1-vs-Stage3 |
6.434000E-01 |
| Stage1-vs-Stage4 |
2.407400E-01 |
| Stage2-vs-Stage3 |
5.648000E-01 |
| Stage2-vs-Stage4 |
9.884400E-01 |
| Stage3-vs-Stage4 |
5.322600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.399100E-03 |
| Normal-vs-AfricanAmerican |
1.417820E-01 |
| Normal-vs-Asian |
3.955900E-03 |
| Caucasian-vs-AfricanAmerican |
6.256000E-01 |
| Caucasian-vs-Asian |
5.511000E-01 |
| AfricanAmerican-vs-Asian |
4.129200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.009370E-04 |
| Normal-vs-Female |
3.804700E-03 |
| Male-vs-Female |
8.962400E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.152100E-02 |
| Normal-vs-Age(41-60Yrs) |
1.803000E-03 |
| Normal-vs-Age(61-80Yrs) |
4.08499999999812E-05 |
| Normal-vs-Age(81-100Yrs) |
5.702400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.921400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.208100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.831200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.193630E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.303600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.223600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.571600E-01 |
| Classical-VS-Follicular |
1.368580E-04 |
| Classical-VS-Other |
1.518240E-01 |
| Classical-VS-Normal |
2.595500E-02 |
| Tall-VS-Follicular |
7.107900E-02 |
| Tall-VS-Other |
2.154800E-01 |
| Tall-VS-Normal |
3.289600E-02 |
| Follicular-VS-Other |
8.758400E-01 |
| Follicular-VS-Normal |
3.56919999999761E-06 |
| Other-VS-Normal |
2.494300E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.35900000000223E-05 |
| Normal-vs-N1 |
3.955900E-04 |
| N0-vs-N1 |
7.203000E-01 |
|
|
